Downregulation of MiR-637 Promotes Vascular Smooth Muscle Cell Proliferation and Migration Via Regulation of Insulin-like Growth Factor-2
Overview
Cell Biology
Molecular Biology
Affiliations
Background: Dysregulation of the proliferation and migration of vascular smooth muscle cells (VSMCs) is a crucial cause of atherosclerosis. MiR-637 exerts an antiproliferative effect on multiple human cells. Its impact on atherosclerosis remains largely unexplored.
Methods: Real-time PCR was used to determine miR-637 expression in samples from atherosclerosis patients and animal models. Its expression in VSMC dysfunction models (induced by ox-LDL) was also measured. The proliferation and migration of VSMCs were respectively tested using CCK-8 and Transwell assays, and apoptosis was measured using flow cytometry. The Targetscan database was used to predict the target genes of miR-637. Interaction between miR-637 and the potential target gene was validated via real-time PCR, western blotting and a luciferase reporter assay.
Results: MiR-637 expression was significantly lower in atherosclerosis patient and animal model samples. It also decreased in a dose- and time-dependent manner in animal models with ox-LDL-induced atherosclerosis. Transfection with miR-637 mimics suppressed the proliferation and migration of VSMCs while promoting apoptosis, while transfection with miR-637 inhibitors had the opposite effects. We also validated that insulin-like growth factor-2 (IGF-2), a crucial factor in the pathogenesis of atherosclerosis, serves as a target gene for miR-637.
Conclusion: MiR-637 targeting IGF-2 contributes to atherosclerosis inhibition and could be a potential target for this disease.
Hou Y, Li X, Wang J, Liu Z, Han M, Liu Z Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(5):1210-1216.
PMID: 39507982 PMC: 11536260. DOI: 10.12182/20240960601.
Zhang T, Cao R, Niu J, Chen Z, Mu S, Cao T Cell Mol Biol Lett. 2024; 29(1):47.
PMID: 38589823 PMC: 11003121. DOI: 10.1186/s11658-024-00566-w.
Xiong Y, Wang Y, Yang T, Luo Y, Xu S, Li L Am J Cardiovasc Drugs. 2023; 23(5):497-518.
PMID: 37524956 DOI: 10.1007/s40256-023-00596-3.
Yang M, Luo J, Zhang S, Huang Q, Cao Q Open Med (Wars). 2023; 18(1):20230687.
PMID: 37415611 PMC: 10320571. DOI: 10.1515/med-2023-0687.
microRNAs Associated with Carotid Plaque Development and Vulnerability: The Clinician's Perspective.
Badacz R, Przewlocki T, Legutko J, Zmudka K, Kablak-Ziembicka A Int J Mol Sci. 2022; 23(24).
PMID: 36555285 PMC: 9779323. DOI: 10.3390/ijms232415645.